Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  MorphoSys    MOR   DE0006632003

MORPHOSYS

(MOR)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations
Most relevant news about MORPHOSYS
11/12MORPHOSYS : Results for Bimagrumab in Obesity and Type 2 Diabetes presented by M..
AQ
11/11MORPHOSYS : Results for Bimagrumab in Obesity and Type 2 Diabetes presented by M..
EQ
11/11MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
11/06MORPHOSYS : to Present Data on Tafasitamab at ASH 2019 Meeting
PU
11/06MORPHOSYS : to Present Data on Tafasitamab at ASH 2019 Meeting
EQ
11/06MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
11/06MORPHOSYS AG : Notification and public disclosure of transactions by persons
EQ
10/30MORPHOSYS AG : - Ad hoc Primary Endpoint met in Real-World Data Study Demonstrat..
AQ
10/29MORPHOSYS : Reports Third Quarter 2019 Financial Results
PU
10/29MORPHOSYS : Reports Third Quarter 2019 Financial Results
EQ
10/29MORPHOSYS AG : Ad hoc: Primary Endpoint met in Real-World Data Study Demonstrati..
PU
10/29MORPHOSYS AG : Primary Endpoint met in Real-World Data Study Demonstrating Clini..
PU
10/29MORPHOSYS AG : Ad hoc: Primary Endpoint met in Real-World Data Study Demonstrati..
EQ
10/29MORPHOSYS AG : Primary Endpoint met in Real-World Data Study Demonstrating Clini..
EQ
10/29MORPHOSYS AG : - Ad hoc MOR106 Clinical Development in Atopic Dermatitis Stopped..
AQ
More most relevant news
All news about MORPHOSYS
11/12MORPHOSYS : Results for Bimagrumab in Obesity and Type 2 Diabetes presented by M..
AQ
11/11MORPHOSYS : Results for Bimagrumab in Obesity and Type 2 Diabetes presented by M..
EQ
11/11MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
11/06MORPHOSYS : to Present Data on Tafasitamab at ASH 2019 Meeting
PU
11/06MORPHOSYS : to Present Data on Tafasitamab at ASH 2019 Meeting
EQ
11/06MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
11/06MORPHOSYS AG : Notification and public disclosure of transactions by persons
EQ
10/30MORPHOSYS AG : - Ad hoc Primary Endpoint met in Real-World Data Study Demonstrat..
AQ
10/29MORPHOSYS : Reports Third Quarter 2019 Financial Results
PU
10/29MORPHOSYS : Reports Third Quarter 2019 Financial Results
EQ
More news
News in other languages on MORPHOSYS
12:06aWOCHENVORSCHAU : Termine bis 28. November 2019
11/11MORPHOSYS' : Partner präsentiert Ergebnisse für Bimagrumab bei starkem Übergewic..
11/11MorphoSys' Partner präsentiert Ergebnisse für Bimagrumab bei starkem Übergewi..
11/11MORPHOSYS AG : Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europawe..
11/06MORPHOSYS : präsentiert Daten zu Tafasitamab auf ASH-Jahrestagung 2019
11/06MorphoSys präsentiert Daten zu Tafasitamab auf ASH-Jahrestagung 2019
11/06MORPHOSYS AG : Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europawe..
11/06MORPHOSYS AG : Meldung und öffentliche Bekanntgabe der Geschäfte von Personen
11/06MorphoSys AG
11/01Deutsche Bank senkt Ziel für Morphosys auf 129 Euro - 'Buy'
Press releases
11/12MORPHOSYS : Results for Bimagrumab in Obesity and Type 2 Diabetes presented by M..
AQ
11/11MORPHOSYS : Results for Bimagrumab in Obesity and Type 2 Diabetes presented by M..
EQ
11/11MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
11/06MORPHOSYS : to Present Data on Tafasitamab at ASH 2019 Meeting
PU
11/06MORPHOSYS : to Present Data on Tafasitamab at ASH 2019 Meeting
EQ
More press releases
Sector news : Biotechnology & Medical Research - NEC
11/14BEIGENE : FDA Gives Accelerated Approval to BeiGene's Brukinsa
DJ
11/14Walt Disney soars while Cisco disappoints
11/14THERMO FISHER SCIENTIFIC : Qiagen Shares Surge on Report Thermo Fisher Mulling D..
DJ
11/07GILEAD SCIENCES : U.S. Sues HIV Drugmaker Gilead Alleging It Infringed on PrEP P..
DJ
11/07GILEAD SCIENCES : U.S. Sues HIV Drugmaker Gilead Alleging It Infringed on PrEP P..
DJ
More sector news : Biotechnology & Medical Research - NEC
Upcoming event on MORPHOSYS